99 related articles for article (PubMed ID: 27453342)
41. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
42. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
43. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
44. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
45. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
46. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.
Wang H; Wang X; Xu L; Zhang J
BMC Pediatr; 2022 Jun; 22(1):376. PubMed ID: 35764946
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
48. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
49. ZNF281 inhibits neuronal differentiation and is a prognostic marker for neuroblastoma.
Pieraccioli M; Nicolai S; Pitolli C; Agostini M; Antonov A; Malewicz M; Knight RA; Raschellà G; Melino G
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):7356-7361. PubMed ID: 29941555
[TBL] [Abstract][Full Text] [Related]
50. Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.
Li SZ; Zeng F; Li J; Shu QP; Zhang HH; Xu J; Ren JW; Zhang XD; Song XM; Du RL
Cancer Lett; 2018 Sep; 431():43-53. PubMed ID: 29803790
[TBL] [Abstract][Full Text] [Related]
51. Regulation of E2 promoter binding factor 1 (E2F1) transcriptional activity through a deubiquitinating enzyme, UCH37.
Mahanic CS; Budhavarapu V; Graves JD; Li G; Lin WC
J Biol Chem; 2015 Oct; 290(44):26508-22. PubMed ID: 26396186
[TBL] [Abstract][Full Text] [Related]
52. TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.
Marshall GM; Bell JL; Koach J; Tan O; Kim P; Malyukova A; Thomas W; Sekyere EO; Liu T; Cunningham AM; Tobias V; Norris MD; Haber M; Kavallaris M; Cheung BB
Oncogene; 2010 Nov; 29(46):6172-83. PubMed ID: 20729920
[TBL] [Abstract][Full Text] [Related]
53. E2F transcription factor-1 modulates expression of glutamine metabolic genes in mouse embryonic fibroblasts and uterine sarcoma cells.
Huber K; Giralt A; Dreos R; Michenthaler H; Geller S; Barquissau V; Ziegler DV; Tavernari D; Gallart-Ayala H; Krajina K; Jonas K; Ciriello G; Ivanisevic J; Prokesch A; Pichler M; Fajas L
Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119721. PubMed ID: 38580088
[TBL] [Abstract][Full Text] [Related]
54. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.
Kim PY; Tan O; Liu B; Trahair T; Liu T; Haber M; Norris MD; Marshall GM; Cheung BB
Cancer Lett; 2016 May; 374(2):315-23. PubMed ID: 26902425
[TBL] [Abstract][Full Text] [Related]
55. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.
Qin G; Kishore R; Dolan CM; Silver M; Wecker A; Luedemann CN; Thorne T; Hanley A; Curry C; Heyd L; Dinesh D; Kearney M; Martelli F; Murayama T; Goukassian DA; Zhu Y; Losordo DW
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):11015-20. PubMed ID: 16835303
[TBL] [Abstract][Full Text] [Related]
56. p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastoma.
Mergui X; Puiffe ML; Valteau-Couanet D; Lipinski M; Bénard J; Amor-Guéret M
BMC Cancer; 2010 Sep; 10():473. PubMed ID: 20813048
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional regulation of the human tumor suppressor DOK1 by E2F1.
Siouda M; Yue J; Shukla R; Guillermier S; Herceg Z; Creveaux M; Accardi R; Tommasino M; Sylla BS
Mol Cell Biol; 2012 Dec; 32(23):4877-90. PubMed ID: 23028047
[TBL] [Abstract][Full Text] [Related]
58. PLAGL2 promotes the stemness and is upregulated by transcription factor E2F1 in human lung cancer.
Lin Y; Lin P; Guo W; Huang J; Xu X; Zhuang X
Environ Toxicol; 2023 Mar; 38(4):941-949. PubMed ID: 36620907
[TBL] [Abstract][Full Text] [Related]
59. Dampened activity of E2F1-DP and Myb-MuvB transcription factors in Drosophila endocycling cells.
Maqbool SB; Mehrotra S; Kolpakas A; Durden C; Zhang B; Zhong H; Calvi BR
J Cell Sci; 2010 Dec; 123(Pt 23):4095-106. PubMed ID: 21045111
[TBL] [Abstract][Full Text] [Related]
60. The E2F1 oncogene transcriptionally regulates NELL2 in cancer cells.
Kim DH; Roh YG; Lee HH; Lee SY; Kim SI; Lee BJ; Leem SH
DNA Cell Biol; 2013 Sep; 32(9):517-23. PubMed ID: 23829315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
